71 – 80 of 89
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation : A 22-year follow-up study
- Contribution to journal › Article
- 2017
-
Mark
Preclinical effects of APOE ϵ4 on cerebrospinal fluid Aβ42 concentrations
- Contribution to journal › Article
-
Mark
Early- versus late-onset Alzheimer's disease in clinical practice : Cognitive and global outcomes over 3 years
- Contribution to journal › Article
-
Mark
Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40)
- Contribution to journal › Article
-
Mark
Cerebrovascular and amyloid pathology in predementia stages : The relationship with neurodegeneration and cognitive decline
- Contribution to journal › Article
- 2016
-
Mark
Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.
- Contribution to journal › Article
-
Mark
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease
- Contribution to journal › Article
- 2015
-
Mark
Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patients.
- Contribution to journal › Article
-
Mark
Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review.
- Contribution to journal › Scientific review
